SCHEMBL6013871

SCHEMBL6013871

O=CCNCC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2009490 0.95
SCHEMBL2332407 0.82
SCHEMBL10621131 0.76
SCHEMBL873741 0.76
SCHEMBL19754094 0.76
SCHEMBL11554261 0.76
SCHEMBL15626471 0.76
SCHEMBL10109002 0.76
SCHEMBL9741536 0.73
Hydrochloric Acid SCHEMBL28614501 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0066103-B1 PROCESS FOR THE REDUCTION OF REDUCIBLE GROUPS, AND ITS APPLICATION Eckert, Heiner, dr. (DE) 1985-08-28 EP claimed
EP-0066103-A1 Process for the reduction of reducible groups, and its application Eckert, Heiner, dr. (DE) 1982-12-08 EP claimed
JP-2010371-A None JP disclosed
JP-2275820-A None JP disclosed
CN-116744944-A Low-immunogenicity biotherapeutic medicine 奥斯普瑞生物制药有限公司 2023-09-12 CN disclosed
EP-3102195-B1 BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS QUADRIGA BIOSCIENCES INC (US) 2021-10-06 EP disclosed
US-20190185413-A1 BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF QUADRIGA BIOSCIENCES, INC. 2019-06-20 US disclosed
CN-106163509-B β -substituted β -amino acids and analogs as chemotherapeutic agents 夸德里加生物科学公司 2019-05-03 CN disclosed
US-10245246-B2 β-substituted β-amino acids and analogs as chemotherapeutic agents QUADRIGA BIOSCIENCES, INC. (US) 2019-04-02 US disclosed
US-10246406-B2 Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof QUADRIGA BIOSCIENCES, INC. (US) 2019-04-02 US disclosed
US-20180297935-A1 BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF QUADRIGA BIOSCIENCES, INC. 2018-10-18 US disclosed
EP-2020405-A1 Substituted aryl or heteroarylpiperidine derivatives as melanocortin-4 receptor modulators Santhera Pharmaceuticals (Schweiz) AG (CH) 2009-02-04 EP disclosed
US-7365190-B2 Crosslinked polysaccharide, obtained by crosslinking with substituted polyethylene glycol, as superabsorbent ARCHER-DANIELS-MIDLAND COMPANY (US) 2008-04-29 US disclosed
US-20080081783-A1 ERYTHROPOIETIN RECEPTOR PEPTIDE FORMULATIONS AND USES AFFYMAX, INC. (US) 2008-04-03 US disclosed
US-7351855-B2 Chemically defined non-polymeric valency platform molecules and conjugates thereof LA JOLLA PHARMACEUTICAL COMPANY (US) 2008-04-01 US disclosed
JP-H02275820-A EXTERNAL ANTIFUNGAL AGENT OTSUKA PHARMACEUT CO LTD 1990-11-09 JP disclosed
JP-H0210371-A ELECTROPHOTOGRAPHIC TONER RICOH CO LTD 1990-01-16 JP disclosed
EP-0066103-B1 PROCESS FOR THE REDUCTION OF REDUCIBLE GROUPS, AND ITS APPLICATION Eckert, Heiner, dr. (DE) 1985-08-28 EP disclosed
US-4537713-A Process for the reduction of reducible groups and its use ECKERT HEINER (DE) 1985-08-27 US disclosed
EP-0066103-A1 Process for the reduction of reducible groups, and its application Eckert, Heiner, dr. (DE) 1982-12-08 EP disclosed